Mal expression in lymphoid cells: Further evidence for mal as a distinct molecular marker of primary mediastinal large B-cell lymphomas

Modern Pathology

Volumn 15, Issue 11, 2002, Pages 1172-1180

  Copie Bergman, Christiane ^a,b,c   Plonquet, Anne ^a,b,c   Alonso, Miguel A ^a,b,c   Boulland, Marie Laure ^a,b,c   Marquet, Jeanine ^a,b,c   Divine, Marine ^a,b,c   Möller, Peter ^a,b,c   Leroy, Karen ^a,b,c   Gaulard, Philippe ^a,b,c  

^a HENRI MONDOR HOSPITAL   (France)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c UNIVERSITY OF ULM   (Germany)

Author keywords

B cell lymphoma; Hodgkin lymphoma; Lymphoid cells; MAL

Indexed keywords

BIOLOGICAL MARKER; CD4 ANTIGEN; CD8 ANTIGEN; PROTEIN MAL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; B CELL LYMPHOMA; BLOOD; CELL LINE; CLINICAL ARTICLE; FLOW CYTOMETRY; HODGKIN DISEASE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; LYMPHOID CELL; LYMPHOID TISSUE; MEDIASTINUM DISEASE; MYELOMA; NEWBORN; PLASMA CELL; PLASMACYTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REED STERNBERG CELL; SPLEEN; T CELL LYMPHOMA; THYMOCYTE; TONSIL; TUMOR CELL;

ANTIGENS, CD; ANTIGENS, CD79; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHOCYTES; LYMPHOMA, B-CELL; MEDIASTINAL NEOPLASMS; MEMBRANE TRANSPORT PROTEINS; MYELIN PROTEINS; PROTEOLIPIDS; RECEPTORS, ANTIGEN, B-CELL; SPLEEN; THYMUS GLAND; TONSIL; TUMOR MARKERS, BIOLOGICAL;

EID: 0036861236     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MP.0000032534.81894.B3     Document Type: Article

References (32)

1. Alonso MA, Weissman SM. cDNA cloning and sequence of MAL, a hydrophobic protein associated with human T-cell differentiation. Proc Natl Acad Sci U S A 1987;84:1997-01.
2. Schaeren-Wiemers N, Valenzuela DM, Frank M, Schwab ME. Characterization of a rat gene, rMAL, encoding a protein with four hydrophobic domains in central and peripheral myelin. J Neurosci 1995;15:5753-64.
3. Zacchetti D, Peranen J, Murata M, Fiedler K, Simons K. VIP17/MAL, a proteolipid in apical transport vesicles. FEBS Lett 1995;377:465-9.
4. Martin-Belmonte F, Kremer L, Albar JP, Marazuela M, Alonso MA. Expression of the MAL gene in the thyroid: The MAL proteolipid, a component of glycolipid-enriched membranes, is apically distributed in thyroid follicles. Endocrinology 1998;139:2077-84.
5. Millán J, Puertollano R, Fan L, Rancano C, Alonso MA. The MAL proteolipid is a component of the detergent-insoluble membrane subdomains of human T-lymphocytes. Biochem J 1997;321:247-52.
6. Puertollano R, Li S, Lisanti MP, Alonso MA. Recombinant expression of the MAL proteolipid, a component of glycolipid-enriched membrane microdomains, induces the formation of vesicular structures in insect cells. J Biol Chem 1997;272:18311-5.
7. Puertollano R, Martin-Belmonte F, Millán J, de Marco MC, Albar JP, Kremer L, et al. The MAL proteolipid is necessary for normal apical transport and accurate sorting of the influenzae virus hemagglutinin in Madin-Darby canine kidney cells. J Cell Biol 1999;145:141-51.
8. Cheong KH, Zacchetti D, Scheeberger EE, Simons K. VIP17/ MAL, a lipid raft-associated protein, is involved in apical transport in MDCK cells. Proc Nad Acad Sci USA 1999;96: 6241-8.
9. Martin-Belmonte F, Puertollano R, Millan J, Alonso MA. The MAL proteolipid is necessary for the overall apical delivery of membrane proteins in the polarized epithelial Madin-Darby canine kidney and Fischer rat thyroid cell lines. Mol Biol Cell 2000;11:2033-45.
10. Millán J, Alonso MA. MAL, a novel integral membrane protein of human T lymphocytes, associates with glycosylphosphatidylinositol-anchored proteins and Src-like tyrosine kinases. Eur J Immunol 1998;28:3675-84.
11. Copie-Bergman C, Gaulard P, Maouche-Chretien L, Brière J, Haioun C, Alonso MA, et al. The MAL gene is expressed in primary mediastinal large B-cell lymphomas. Blood 1999;94:3567-75.
12. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JCK, Clearly ML, et al. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 1994;84:1361-92.
13. Rancano C, Rubio T, Correas I, Alonso MA. Genomic structure and subcellular localization of MAL, a human T-cell-specific proteolipid protein. J Biol Chem 1994;269:8159-64.
14. Rancano C, Rubio T, Alonso MA. Alternative splicing of human T-cell-specific MAL mRNA and its correlation with the exon/intron organization of the gene. Genomics 1994;21: 447-50.
15. Möller P, Brüderlein S, Sträter J, Leithäuser F, Hasel C, Bataille F, et al. MedB-1, a human tumor cell line derived from primary mediastinal large B-cell lymphoma. Int J Cancer 2001;92:348-53.
16. Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001.
17. Isaacson PG, Norton AJ, Addis BJ. The human thymus contains a novel population of B lymphocytes. Lancet 1987;2:1488-91.
18. Hofmann WJ, Momburg F, Möller P. Thymic medullary cells expressing B cell antigens. Hum Pathol 1988;19:1280-7.
19. Dunn-Walters DK, Howe CJ, Isaacson PGI, Spencer J. Location and sequence of rearranged immunoglobulin genes in human thymus. Eur J Immunol 1995;25:513-9.
20. Flores KG, LI J, Hale LP. B cells in epithelial and perivascular compartments of human adult thymus. Hum Pathol 2001;32:926-34.
21. Möller P, Moldenhauer G, Momburg F, Lämmler B, Eberlein-Gonska M, Kiesel S, et al. Mediastinal lymphoma of clear cell type is a tumor corresponding to terminal steps of B cell differentiation. Blood 1987;69:1087-95.
22. De Leval L, Ferry JA, Falini B, Shipp M, Harris NL. Expression of bcl-6 and CD10 in primary mediastinal large B-cell lymphoma. Evidence for derivation from germinal center B cells? Am J Surg Pathol 2001;25:1277-82.
23. Leithäuser F, Bäuerle M, Quang Huynh M, Möller P. Isotype-switched immunoglobulin genes with a high load of somatic hypermutation and lack of ongoing mutational activity are prevalent in mediastinal B-cell lymphoma. Blood 2001;98:2762-70.
24. Higgins JP, Warnke RA. CD30 expression is common in mediastinal large B-cell lymphoma. Am J Clin Pathol 1999;112:241-7.
25. Rüdiger T, Jaffe ES, Delsol G, de Wolf-Peeters C, Gascoyne RD, Georgii A, et al. Workshop report on Hodgkin's disease and related diseases ("grey zone" lymphoma). Ann Oncol 1998;9(Suppl 5):31-8.
26. Cazals-Hatem D, André M, Mounier N, Copin MC, Divine M, Berger F, et al. Pathologic and clinical features of 77 Hodgkin's lymphoma patients treated in a lymphoma protocol (LNH87). A GELA study. Am J Surg Pathol 2001;25:297-306.
27. Kim T, Fiedler K, Madison DL, Krueger WH, Pfeiffer SE. Cloning and characterization of MVP17: A developmentally regulated myelin protein in oligodendrocytes. J Neurosci Res 1995;42:413-22.
28. Gisou van der Goot F, Harder T. Raft membrane domains: From a liquid-ordered membrane phase to a site of pathogen attack. Semin Immunol 2001;13:89-97.
29. Carrie Miceli M, Moran M, Chung CD, Patel VP, Low T, Zinnanti W. Co-stimulation and counterstimulation: Lipid raft clustering controls TCR signaling and functional outcomes. Semin Immunol 2001;13:115-28.
30. Leitenberg D, Balamuth F, Bottomly K. Changes in the T cell receptor macromolecular signaling complex and membrane microdomains during T cell development and activation. Semin Immunol 2001;13:129-38.
31. Alonso MA, Millán J. The role of lipid rafts in signalling and membrane trafficking in T lymphocytes. J Cell Sci 2001;114:3957-65.
32. Cheng PC, Cherukuri A, Dykstra M, Malapati S, Sproul T, Chen MR, et al. Floating, the raft hypothesis: The role of lipid rafts in B cell antigen receptor function. Semin Immunol 2001;13:107-14.